logo
  

Cardinal Health Gets FDA Approval For Lymphoseek Pediatric Indication

Cardinal Health (CAH) said that the U.S. Food and Drug Administration has approved Lymphoseek (technetium Tc 99m tilmanocept) injection for pediatric use. Lymphoseek is radiopharmaceutical agent specifically designed for targeted lymphatic mapping and guiding sentinel lymph node biopsies or SLNB.

In addition to adult use, the new indication will provide lymph node identification in pediatric patients with melanoma, rhabdomyosarcoma or other types of solid tumors. This will offer physicians, oncologists and nuclear medicine specialists an efficient, accurate and safe option to enhance lymphatic mapping and SLNB in pediatric melanoma cases, the most common skin cancer in children.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Goldman Sachs Group, Inc. (GS) reported that its third quarter net earnings applicable to common shareholders increased 63 percent year-on-year. Net revenues were also significantly higher reflecting significantly higher net revenues in Investment Banking, Global Markets and Consumer & Wealth Management,... Butterball, LLC recalled about 14,107 pounds of ground turkey products for potential contamination with foreign materials, specifically blue plastic material, the U.S. Department of Agriculture's Food Safety and Inspection Service (FSIS) said in a statement. Specialized Bicycle Components, Inc. is recalling about 6,900 units of Tarmac SL7 Bicycles and Framesets for potential risk of fall and injury hazard, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said the bicycle's fork steerer tube can crack or break after harsh impact such as hitting a deep pothole or other stress event, posing fall and injury hazards.
Follow RTT